NO20061509L - Selektiv syntese av CF3-substituerte pyrimidiner - Google Patents
Selektiv syntese av CF3-substituerte pyrimidinerInfo
- Publication number
- NO20061509L NO20061509L NO20061509A NO20061509A NO20061509L NO 20061509 L NO20061509 L NO 20061509L NO 20061509 A NO20061509 A NO 20061509A NO 20061509 A NO20061509 A NO 20061509A NO 20061509 L NO20061509 L NO 20061509L
- Authority
- NO
- Norway
- Prior art keywords
- formula
- substituted pyrimidines
- selective synthesis
- compound
- hnr4r4
- Prior art date
Links
- 150000003230 pyrimidines Chemical class 0.000 title abstract 2
- 230000015572 biosynthetic process Effects 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000002841 Lewis acid Substances 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 150000001412 amines Chemical class 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 230000010261 cell growth Effects 0.000 abstract 1
- 150000007517 lewis acids Chemical class 0.000 abstract 1
- 210000004962 mammalian cell Anatomy 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000000269 nucleophilic effect Effects 0.000 abstract 1
- 229940083082 pyrimidine derivative acting on arteriolar smooth muscle Drugs 0.000 abstract 1
- YAAWASYJIRZXSZ-UHFFFAOYSA-N pyrimidine-2,4-diamine Chemical group NC1=CC=NC(N)=N1 YAAWASYJIRZXSZ-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Catalysts (AREA)
Abstract
Det er beskrevet en fremgangsmåte for å fremstille en forbindelse av formel (I), hvor X\ X^ og R^-R'' er som definert heri. Fremgangsmåten omfatter omsetning av en forbindelse av formel (II) med et amin av formel (III) (HNR^R'') i nærvær av en Lewis syre og en ikke-nukleofil base. 2,4-diaminopyrimidinenheten er en felles komponent i en rekke biologisk aktive, legemiddel-lignende molekyler og pyrimidinderivater er furmet å være nyttige i behandlingen av abnormal ceUevekst, så som kreft, i pattedyr.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US50073303P | 2003-09-05 | 2003-09-05 | |
| PCT/IB2004/002744 WO2005023780A1 (en) | 2003-09-05 | 2004-08-24 | Selective synthesis of cf3-substituted pyrimidines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20061509L true NO20061509L (no) | 2006-04-03 |
| NO334383B1 NO334383B1 (no) | 2014-02-24 |
Family
ID=34272990
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20061509A NO334383B1 (no) | 2003-09-05 | 2006-04-03 | Fremgangsmåte for fremstilling av av CF3-substituerte pyrimidiner |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US7122670B2 (no) |
| EP (1) | EP1663991B1 (no) |
| JP (1) | JP4842816B2 (no) |
| KR (1) | KR100694732B1 (no) |
| CN (1) | CN100465164C (no) |
| AR (1) | AR045557A1 (no) |
| BR (1) | BRPI0414059B8 (no) |
| CA (1) | CA2537373C (no) |
| CO (1) | CO5650237A2 (no) |
| CY (1) | CY1106370T1 (no) |
| DE (1) | DE602004004287T2 (no) |
| DK (1) | DK1663991T3 (no) |
| ES (1) | ES2276344T3 (no) |
| HK (1) | HK1091824A1 (no) |
| IL (1) | IL173363A (no) |
| MX (1) | MXPA06002552A (no) |
| NO (1) | NO334383B1 (no) |
| NZ (1) | NZ544969A (no) |
| PL (1) | PL1663991T3 (no) |
| PT (1) | PT1663991E (no) |
| RU (1) | RU2315759C2 (no) |
| TW (1) | TWI283667B (no) |
| WO (1) | WO2005023780A1 (no) |
| ZA (1) | ZA200600747B (no) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60331479D1 (de) * | 2002-12-20 | 2010-04-08 | Pfizer Prod Inc | Pyrimidin-derivate zur behandlung von anormalem zellwachstum |
| US20060205945A1 (en) * | 2004-05-14 | 2006-09-14 | Pfizer Inc | Pyrimidine derivatives for the treatment of abnormal cell growth |
| JP4778717B2 (ja) * | 2005-03-25 | 2011-09-21 | 富士フイルム株式会社 | 複素環式化合物の製造方法 |
| DE102007010801A1 (de) | 2007-03-02 | 2008-09-04 | Bayer Cropscience Ag | Diaminopyrimidine als Fungizide |
| DK2146779T3 (en) * | 2007-04-18 | 2016-11-28 | Pfizer Prod Inc | Sulfonylamid derivatives to treat abnormal cell growth. |
| KR101294731B1 (ko) * | 2007-06-04 | 2013-08-16 | 삼성디스플레이 주식회사 | 어레이 기판, 이를 갖는 표시패널 및 이의 제조방법 |
| UY31714A (es) | 2008-03-20 | 2009-11-10 | Boehringer Ingelheim Int | Preparación selectiva de pirimidinas sustituidas |
| EP2268621A1 (en) | 2008-03-20 | 2011-01-05 | Boehringer Ingelheim International GmbH | Regioselective preparation of substituted pyrimidines |
| DE102009006643A1 (de) | 2009-01-29 | 2010-08-05 | Saltigo Gmbh | Herstellung von halogenierten N-heteroaromatischen Polyhalogenderivaten |
| TW201100441A (en) | 2009-06-01 | 2011-01-01 | Osi Pharm Inc | Amino pyrimidine anticancer compounds |
| WO2011018517A1 (en) | 2009-08-14 | 2011-02-17 | Boehringer Ingelheim International Gmbh | Regioselective preparation of 2-amino-5-trifluoromethylpyrimidine derivatives |
| US8933227B2 (en) * | 2009-08-14 | 2015-01-13 | Boehringer Ingelheim International Gmbh | Selective synthesis of functionalized pyrimidines |
| EP2646448B1 (en) | 2010-11-29 | 2017-08-30 | OSI Pharmaceuticals, LLC | Macrocyclic kinase inhibitors |
| UY33817A (es) | 2010-12-21 | 2012-07-31 | Boehringer Ingelheim Int | ?nuevas oxindolpirimidinas bencílicas?. |
| ES2691673T3 (es) | 2011-02-17 | 2018-11-28 | Cancer Therapeutics Crc Pty Limited | Inhibidores de Fak |
| WO2012110774A1 (en) | 2011-02-17 | 2012-08-23 | Cancer Therapeutics Crc Pty Limited | Selective fak inhibitors |
| WO2014126954A1 (en) | 2013-02-13 | 2014-08-21 | OSI Pharmaceuticals, LLC | Regioselective synthesis of substituted pyrimidines |
| US9656970B2 (en) | 2014-05-08 | 2017-05-23 | Tosoh F-Tech, Inc. | 5-(trifluoromethyl)pyrimidine derivatives and method for producing same |
| JP6391985B2 (ja) * | 2014-05-16 | 2018-09-19 | 東ソー・ファインケム株式会社 | ２−置換−４−（２，２，２−トリフルオロエトキシ）−５−（トリフルオロメチル）ピリミジン誘導体及びその製造方法 |
| JP6391988B2 (ja) * | 2014-05-21 | 2018-09-19 | 東ソー・ファインケム株式会社 | ５−（トリフルオロメチル）ピリミジン誘導体の製造方法及び新規５−（トリフルオロメチル）ピリミジン誘導体 |
| CN108440499A (zh) * | 2018-03-22 | 2018-08-24 | 盐城师范学院 | 一种色瑞替尼及其关键中间体的制备方法 |
| CN114213339B (zh) * | 2021-12-20 | 2023-10-31 | 苏州康纯医药科技有限公司 | 一种表皮细胞生长因子受体突变抑制剂的制备方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003030909A1 (en) * | 2001-09-25 | 2003-04-17 | Bayer Pharmaceuticals Corporation | 2- and 4-aminopyrimidines n-substtituded by a bicyclic ring for use as kinase inhibitors in the treatment of cancer |
| CA2463989C (en) * | 2001-10-17 | 2012-01-31 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pyrimidine derivatives, pharmaceutical compositions containing these compounds, the use thereof and process for the preparation thereof |
-
2004
- 2004-08-24 WO PCT/IB2004/002744 patent/WO2005023780A1/en active IP Right Grant
- 2004-08-24 CA CA002537373A patent/CA2537373C/en not_active Expired - Lifetime
- 2004-08-24 PT PT04769170T patent/PT1663991E/pt unknown
- 2004-08-24 ES ES04769170T patent/ES2276344T3/es not_active Expired - Lifetime
- 2004-08-24 DK DK04769170T patent/DK1663991T3/da active
- 2004-08-24 RU RU2006106727/04A patent/RU2315759C2/ru not_active IP Right Cessation
- 2004-08-24 KR KR1020067004428A patent/KR100694732B1/ko active IP Right Grant
- 2004-08-24 JP JP2006525198A patent/JP4842816B2/ja not_active Expired - Lifetime
- 2004-08-24 BR BRPI0414059A patent/BRPI0414059B8/pt active IP Right Grant
- 2004-08-24 PL PL04769170T patent/PL1663991T3/pl unknown
- 2004-08-24 DE DE602004004287T patent/DE602004004287T2/de not_active Expired - Lifetime
- 2004-08-24 CN CNB2004800254318A patent/CN100465164C/zh not_active Expired - Lifetime
- 2004-08-24 MX MXPA06002552A patent/MXPA06002552A/es active IP Right Grant
- 2004-08-24 NZ NZ544969A patent/NZ544969A/en not_active IP Right Cessation
- 2004-08-24 EP EP04769170A patent/EP1663991B1/en not_active Expired - Lifetime
- 2004-08-27 US US10/928,954 patent/US7122670B2/en not_active Expired - Lifetime
- 2004-09-02 AR ARP040103140A patent/AR045557A1/es not_active Application Discontinuation
- 2004-09-03 TW TW093126748A patent/TWI283667B/zh not_active IP Right Cessation
-
2006
- 2006-01-25 IL IL173363A patent/IL173363A/en active IP Right Grant
- 2006-01-26 ZA ZA200600747A patent/ZA200600747B/xx unknown
- 2006-02-23 CO CO06018320A patent/CO5650237A2/es not_active Application Discontinuation
- 2006-04-03 NO NO20061509A patent/NO334383B1/no unknown
- 2006-11-09 HK HK06112349.7A patent/HK1091824A1/xx not_active IP Right Cessation
-
2007
- 2007-03-12 CY CY20071100341T patent/CY1106370T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20061509L (no) | Selektiv syntese av CF3-substituerte pyrimidiner | |
| DE60019317D1 (de) | Chinazolinderivate | |
| NO20074055L (no) | Prosesser for a fremstille 4-(fenoksy-5-metylpyrimidin-4-yloksy)piperidin-1-karboksylsyrederivater og relaterte forbindelser | |
| CN111454327B (zh) | 一种nampt蛋白降解靶向嵌合体及其制备方法和应用 | |
| AU2006258051A1 (en) | Process for the synthesis of 5- (methyl-1H-imidazol-1-yl) -3- (tri fluorome th yl) -benzeneamine | |
| DK1038875T3 (da) | Imidazopyridine- derivativer og fremgangsmåde til fremstilling deraf | |
| NO20064576L (no) | Pyrimidin-derivater for behandling av avvikende celle vekst | |
| CA2499822A1 (en) | Novel pyrimidineamide derivatives and the use thereof | |
| NO333251B1 (no) | Fremgangsmate for fremstilling av N-substituerte 2-cyanopyrrolidoner | |
| DK208287A (da) | 4(5)-substituerede imidazolderivater og fremgangsmaade til fremstilling deraf | |
| EA200600046A1 (ru) | Производные 6-[2-(фосфонометокси)алкокси]пиримидинов (варианты), способ их получения (варианты), фармацевтическая композиция на их основе и способ лечения вирусной инфекции | |
| MY137356A (en) | Novel substituted 4-phenyl-4-[1h-imidazol-2-yl]-piperidine derivatives and their use as selective non-peptide delta-opioid agonists | |
| WO2003078396A8 (en) | Preparation of n1-(2’-pyridyl)-1,2-propanediamine sulfamic acid and its use in the synthesis of biologically active piperazines | |
| US3898230A (en) | Sydnone imine compounds | |
| CA1037953A (en) | 2,4-diamino-5-benzylpyrimidines | |
| WO2005063720A1 (ja) | アミド誘導体及び医薬 | |
| BR0105800A (pt) | Processo para produção de ester de ácido amico | |
| HUP0000726A2 (hu) | Eljárás flukonazol előállítására | |
| US5234925A (en) | 2-aza-2-desamino analogues of 5,8-dideazafolic acid | |
| EP0223124B1 (en) | Substituted aminosulfonyl 6-nitrobenzoic-esters or amides, processes for their preparation and pharmaceutical compositions containing them | |
| DK0504290T3 (da) | Inhibitorer af dihydrofylatreduktase fra Pneumocystis carinii | |
| EP1188752A4 (en) | A METHOD FOR PRODUCING SUBSTITUTED ALKYLAMINE DERIVATIVES | |
| CA2468542A1 (en) | Synthesis of 2-cyanoaziridine-1-carboxamide | |
| Blackie et al. | Inhibition of trypanothione reductase and glutathione reductase by ferrocenic 4-aminoquinoline ureas | |
| HRP20030854A2 (en) | Process for preparing fluconazole and its crystal modifications |